dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | González-Martínez, Silvia |
dc.contributor.author | Pérez-Mies, Belén |
dc.contributor.author | Pizarro, David |
dc.contributor.author | Caniego-Casas, Tamara |
dc.contributor.author | Cortés Castan, Javier |
dc.contributor.author | Palacios, José |
dc.date.accessioned | 2022-01-31T11:03:01Z |
dc.date.available | 2022-01-31T11:03:01Z |
dc.date.issued | 2021-07 |
dc.identifier.citation | González-Martínez S, Pérez-Mies B, Pizarro D, Caniego-Casas T, Cortés J, Palacios J. Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma. Int J Mol Sci. 2021 Jul;22(14):7398. |
dc.identifier.issn | 1422-0067 |
dc.identifier.uri | https://hdl.handle.net/11351/6937 |
dc.description | Transició epitelial-mesenquimal; Carcinoma de mama metaplàstic |
dc.description.sponsorship | This review was funded by grants from the Instituto de Salud Carlos III (ISCIII) (PI19/01331) and CIBERONC (CB16/12/00316 and CB16/12/00449), co-financed by the European Development Regional Fund. ‘A way to achieve Europe’ (FEDER), and by the Spanish Association Against Cancer Scientific Foundation (Grupos Coordinados Traslacionales aecc 2018). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | International Journal of Molecular Sciences;22(14) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Tractament |
dc.subject | Cèl·lules - Transformació |
dc.subject | Fisiologia cel·lular |
dc.subject.mesh | Epithelial-Mesenchymal Transition |
dc.subject.mesh | /drug effects |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | /immunology |
dc.title | Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/ijms22147398 |
dc.subject.decs | transición epiteliomesenquimatosa |
dc.subject.decs | /efectos de los fármacos |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | /inmunología |
dc.relation.publishversion | https://doi.org/10.3390/ijms22147398 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [González-Martínez S] Clinical Researcher, Hospital Ramón y Cajal, 28034 Madrid, Spain. [Pérez-Mies B, Palacios J] Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain. Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain. CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain. Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, 28801 Madrid, Spain. [Pizarro D, Caniego-Casas T] Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain. [Cortés J] CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain. Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, 28670 Madrid, Spain. International Breast Cancer Center (IBCC), Quironsalud Group, 08017 Barcelona, Spain. Medica Scientia Innovation Research, 08007 Barcelona, Spain. Medica Scientia Innovation Research, Ridgewood, NJ 07450, USA. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34299016 |
dc.identifier.wos | 000676513000001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00449 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |